Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements reported a 69.9% YoY revenue jump to ₹35,044.76 crores for FY2025, driven by strategic acquisitions and capacity expansion, while profit after tax rose 10.5% to ₹5,158.41 crores. The company declared a ₹2 dividend per share and appointed four independent directors for second terms, including former SBI Chairman Rajnish Kumar. Ongoing Competition Commission litigation remains a risk, but no financial provisions were made.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 29 April 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 29 April 2025

SHRIRAMFIN Shriram Finance Limited Financial Results TRENT Trent Limited Corporate Action TRENT Trent Limited Financial Results TRENT Trent Limited Corporate Action TRENT Trent Limited Financial Results ULTRACEMCO UltraTech Cement Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.